1849-53-2

Basic information

• Product Name: 3-METHOXY-PYRIDINE-2-CARBALDEHYDE
• Synonyms: 3-METHOXY-2-PYRIDINECARBOXALDEHYDE;3-METHOXY-PYRIDINE-2-CARBALDEHYDE;3-METHOXY-PYRIDINECARBOXALDEHYDE;3-Methoxypyridine-2-carboxaldehyde;3-Methoxypicolinaldehyde;3-Methoxy-2-pyridinecarboxaldehyde ,97%
• CAS NO: 1849-53-2
• Molecular Formula: C₇H₇NO₂
• Molecular Weight: 137.14
• Product Categories: Aldehydes;Pyridines
• Mol File: 1849-53-2.mol
• Article Data: 9

Chemical Properties

• Melting Point: 67-68 °C
• Boiling Point: 239.371 °C at 760 mmHg
• Flash Point: 98.568 °C
• Appearance: /
• Density: 1.159 g/cm³
• Vapor Pressure: 0.0403mmHg at 25°C
• Refractive Index: 1.551
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• PKA: 3.19±0.10(Predicted)
• CAS DataBase Reference: 3-METHOXY-PYRIDINE-2-CARBALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-METHOXY-PYRIDINE-2-CARBALDEHYDE(1849-53-2)
• EPA Substance Registry System: 3-METHOXY-PYRIDINE-2-CARBALDEHYDE(1849-53-2)

Safety Data

• Hazard Codes: Xn
• Statements: 22-37/38-41
• Safety Statements: 26-39
• Hazardous Substances Data: 1849-53-2(Hazardous Substances Data)

Usage

Uses

3-Methoxypyridine-2-carbaldehyde is a useful reactant and reagent for organic reactions and synthesis.

Synthesis Reference(s)

Tetrahedron Letters, 29, p. 773, 1988 DOI: 10.1016/S0040-4039(00)80206-3

InChI:InChI=1/C7H7NO2/c1-10-7-3-2-4-8-6(7)5-9/h2-5H,1H3

Upstream product

• 7295-76-3 3-methoxypyridine 
• 576-83-0 2,4,6-trimethylphenyl bromide 
• 38749-79-0 3-bromo-2-picoline 
• 26395-26-6 3-methoxy-2-methylpyridine 
• 626-60-8 3-Chloropyridine 
• 110-89-4 piperidine 
• 14173-30-9 3-hydroxy-2-hydroxymethylpyridine hydrochloride 
• 130113-09-6 (3-Methoxy-pyridin-2-yl)-methanediol 
• 51984-46-4 2-Hydroxymethyl-3-methoxy pyridine 
• 68-12-2 N,N-dimethyl-formamide 
• 100055-71-8 3-methoxy-pyridine-2-carbaldehyde-diethylacetal 
• 1849-55-4 2-Formyl-3-hydroxypyridin 
• 80-48-8 methyl p-toluene sulfonate 
• 100193-35-9 3-acetoxy-2-diacetoxymethyl-pyridine 

Downstream Products

• 1416801-44-9 (S)-(3-methoxypyridin-2-yl)(4-(trifluoromethyl)phenyl)methanamine 
• 1416801-46-1 (S)-N-((S)-(3-methoxypyridin-2-yl)(4-(trifluoromethyl)phenyl)-methyl)-2-methylpropane-2-sulfinamide 
• 123506-69-4 3-Methoxy-4-methyl-2-pyridinecarboxaldehyde 
• 51984-14-6 3-methoxy-pyridine-2-carbaldehyde-thiosemicarbazone 

Relevant articles and documents

Multi-substituted amine compound and its preparation and use (by machine translation)

The invention belongs to the field of medical technology, in particular, the present invention provides the following formula I shown multi-substituted amine compound or its isomer or its pharmaceutically acceptable salt, ester, prodrug or hydrate, its pharmaceutical composition, preparation method thereof and its use in the preparation of medicine for treating aids in use. The compound or pharmaceutical composition containing the compound can be used as an inhibitor for inhibiting HIV integrase with LEDGF/p75 between protein - protein interaction and HIV integrase dimerization, then can be used for the treatment of aids. . (by machine translation)

SUBSTITUTED 4-AMINO-1-(PYRIDYLMETHYL)PIPERIDINE AND RELATED COMPOUNDS

This invention provides 4-amino-1-(pyridylmethyl)piperidine and related compounds and pharmaceutically acceptable salts thereof which are useful as muscarinic receptor antagonists. This invention also provides pharmaceutical compositions containing such compounds; processes and intermediates useful for preparing such compounds; and methods for treating disease conditions mediated by muscarinic receptors, such as overactive bladder, irritable bowel syndrome and chronic obstructive pulmonary disease, using such compounds.

Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof

Substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts, pharmaceutical compositions containing them, and methods for the treatment of neurodegenerative disorders or neurotoxic injuries utilizing them, wherein the substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts have the formula: STR1 wherein: R1, R2, R3, R4, R5, R6, R7, X and p are as defined in the specification.